The clinical utility of the calcitonin gene–related peptide (CGRP) receptor antagonist ubrogepant may extend beyond the treatment of acute migraine to alleviating common prodromal symptoms of migraine ...

Please provide your email address to receive an email when new articles are posted on . Increased consumption of unprocessed foods boosted odds of nonmotor prodromal Parkinson’s symptoms. Greater odds ...

A migraine drug called ubrogepant doesn't just reduce the severity of a migraine attack – it also dials down the non-headache symptoms in the prodrome: the hours leading up to the main event. That's ...

The most common prodromal symptom of Parkinson disease among community-dwelling older adults was cognitive deficit, followed by subthreshold parkinsonism, urinary dysfunction, and olfactory ...

Several known risk factors and prodromal features were associated with Parkinson disease, including traumatic brain injury and alcohol misuse, along with other comorbidities such as skin and ...

If you have migraine, you probably know the signs of an attack all too well: A throbbing headache, nausea, and sensitivity to certain lights and sounds can be hell. But you might also notice that you ...

Please provide your email address to receive an email when new articles are posted on . Participants with word-finding issues reported concentration trouble, and vice versa. No cognitive performance ...

A drug to treat migraine, ubrogepant, is also found to reduce common non-headache symptoms that occur in the hours preceding a migraine headache, according to the results of a large phase three ...

Migraine isn’t simply a “bad headache” — it’s a complex neurological disease that can affect your entire brain and body before, during, and after the painful headache attack. Since 2018, several new ...

Absence of photophobia at 2 hours postdose occurred in 19.5 and 12.5% of ubrogepant- and placebo-treated events, respectively. HealthDay News — Ubrogepant during the prodromal phase of migraine may ...